Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 4

Characterizing blood microparticles: Technical aspects and challenges

Authors Arun S Shet

Published Date September 2008 Volume 2008:4(4) Pages 769—774

DOI http://dx.doi.org/10.2147/VHRM.S955

Published 4 September 2008

Arun S Shet

Department of Medicine, St. Johns Medical College and Hospital, St. Johns National Academy of Health Sciences, Bangalore, India

Abstract: Although long considered to be cellular debris, microparticles (MPs) are more recently considered refl ective of cellular stimulation, activation, and degeneration/apoptosis. MPs that arise from the cellular components of blood and the endothelial lining of blood vessels are referred to as blood MPs and by general consensus are small (≤1.5 μm), expose the anionic phospholipid (PL) phosphatidylserine (PS) on the outer leaflet of their membrane, and bear surface membrane antigens refl ecting their cellular origin. This brief review summarizes the different approaches used by several groups to study blood MPs. The aim of this article is to review the technical aspects of characterizing the morphological and functional properties of blood MPs with emphasis on the preanalytical and analytical variables involved in these studies.

Keywords: microparticles, flow cytometry, techniques

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Effects of safflower seed extract on arterial stiffness

Katsuya Suzuki, Shigekazu Tsubaki, Masami Fujita, et al

Vascular Health and Risk Management 2010, 6:1007-1014

Published Date: 3 November 2010

Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature

Kathleen Stergiopoulos, Joseph J Brennan, Robin Mathews, John F Setaro, Smadar Kort

Vascular Health and Risk Management 2008, 4:1475-1480

Published Date: 20 November 2008

Gadofosveset-enhanced magnetic resonance angiography

Mathias Goyen

Vascular Health and Risk Management 2008, 4:1-9

Published Date: 5 March 2008

Cholesterol lowering for secondary prevention: What statin dose should we use?

Kiranbir Josan, Finlay A McAlister

Vascular Health and Risk Management 2007, 3:615-627

Published Date: 20 November 2007

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients

Ana T Rocha, Edison F Paiva, Arnaldo Lichtenstein, Rodolfo Milani Jr, Cyrillo Cavalheiro-Filho,
Francisco H Maffei

Vascular Health and Risk Management 2007, 3:533-553

Published Date: 4 October 2007

Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity

Barbara Ludolph, Wilhelm Bloch, Malte Kelm, Rainer Schulz, Petra Kleinbongard

Vascular Health and Risk Management 2007, 3:1069-1073

Published Date: 15 January 2007

Hypothyroidism in coronary heart disease and its relation to selected risk factors

Otto Mayer Jr, Jaroslav Šimon, Jan Filipovský, Markéta Plášková, Richard Pikner

Vascular Health and Risk Management 2006, 2:499-506

Published Date: 2 March 2006

Screening for popliteal aneurysms should not be a routine part of a community-based aneurysm screening program

Martin Claridge, Simon Hobbs, Clive Quick, Donald Adam, Andrew Bradbury, Teun Wilmink

Vascular Health and Risk Management 2006, 2:189-191

Published Date: 25 January 2006

Metabolic syndrome: the danger signal in atherosclerosis

Patrick Mathieu, Philippe Pibarot, Jean-Pierre Després

Vascular Health and Risk Management 2006, 2:285-302

Published Date: 25 January 2006